These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 29902993)

  • 1. Impact of pre-diagnostic triglycerides and HDL-cholesterol on breast cancer recurrence and survival by breast cancer subtypes.
    Lofterød T; Mortensen ES; Nalwoga H; Wilsgaard T; Frydenberg H; Risberg T; Eggen AE; McTiernan A; Aziz S; Wist EA; Stensvold A; Reitan JB; Akslen LA; Thune I
    BMC Cancer; 2018 Jun; 18(1):654. PubMed ID: 29902993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum lipids and outcome of early-stage breast cancer: results of a prospective cohort study.
    Bahl M; Ennis M; Tannock IF; Hux JE; Pritchard KI; Koo J; Goodwin PJ
    Breast Cancer Res Treat; 2005 Nov; 94(2):135-44. PubMed ID: 16261412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of preoperative serum triglycerides and high-density lipoprotein-cholesterol levels on the prognosis of breast cancer.
    Li X; Tang H; Wang J; Xie X; Liu P; Kong Y; Ye F; Shuang Z; Xie Z; Xie X
    Breast; 2017 Apr; 32():1-6. PubMed ID: 27939967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast-conserving therapy for triple-negative breast cancer.
    Gangi A; Chung A; Mirocha J; Liou DZ; Leong T; Giuliano AE
    JAMA Surg; 2014 Mar; 149(3):252-8. PubMed ID: 24382582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoprotein subfractions by nuclear magnetic resonance are associated with tumor characteristics in breast cancer.
    Flote VG; Vettukattil R; Bathen TF; Egeland T; McTiernan A; Frydenberg H; Husøy A; Finstad SE; Lømo J; Garred Ø; Schlichting E; Wist EA; Thune I
    Lipids Health Dis; 2016 Mar; 15():56. PubMed ID: 26970778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood lipids and lipoproteins in relation to incidence and mortality risks for CVD and cancer in the prospective EPIC-Heidelberg cohort.
    Katzke VA; Sookthai D; Johnson T; Kühn T; Kaaks R
    BMC Med; 2017 Dec; 15(1):218. PubMed ID: 29254484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical features and prognosis of patients with first-episode liver metastasis of different molecular subtypes of breast cancer].
    Wu SY; Tan Y; Guan YS
    Zhonghua Gan Zang Bing Za Zhi; 2016 Jun; 24(6):422-8. PubMed ID: 27465945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective associations between serum biomarkers of lipid metabolism and overall, breast and prostate cancer risk.
    His M; Zelek L; Deschasaux M; Pouchieu C; Kesse-Guyot E; Hercberg S; Galan P; Latino-Martel P; Blacher J; Touvier M
    Eur J Epidemiol; 2014 Feb; 29(2):119-32. PubMed ID: 24519551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triple negative breast cancer in Korea-distinct biology with different impact of prognostic factors on survival.
    Lee JA; Kim KI; Bae JW; Jung YH; An H; Lee ES;
    Breast Cancer Res Treat; 2010 Aug; 123(1):177-87. PubMed ID: 20574671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ten-year recurrence rates for breast cancer subtypes in the Netherlands: A large population-based study.
    van Maaren MC; de Munck L; Strobbe LJA; Sonke GS; Westenend PJ; Smidt ML; Poortmans PMP; Siesling S
    Int J Cancer; 2019 Jan; 144(2):263-272. PubMed ID: 30368776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A case-control study on the association between serum lipid level and the risk of breast cancer].
    Wei LJ; Zhang C; Zhang H; Wei X; Li SX; Liu JT; Ren XB
    Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Dec; 50(12):1091-1095. PubMed ID: 28057114
    [No Abstract]   [Full Text] [Related]  

  • 12. Prediagnostic serum glucose and lipids in relation to survival in breast cancer patients: a competing risk analysis.
    Wulaningsih W; Vahdaninia M; Rowley M; Holmberg L; Garmo H; Malmstrom H; Lambe M; Hammar N; Walldius G; Jungner I; Coolen AC; Van Hemelrijck M
    BMC Cancer; 2015 Nov; 15():913. PubMed ID: 26577580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breastfeeding, PAM50 tumor subtype, and breast cancer prognosis and survival.
    Kwan ML; Bernard PS; Kroenke CH; Factor RE; Habel LA; Weltzien EK; Castillo A; Gunderson EP; Maxfield KS; Stijleman IJ; Langholz BM; Quesenberry CP; Kushi LH; Sweeney C; Caan BJ
    J Natl Cancer Inst; 2015 Jul; 107(7):. PubMed ID: 25921910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-diagnostic high-sensitive C-reactive protein and breast cancer risk, recurrence, and survival.
    Frydenberg H; Thune I; Lofterød T; Mortensen ES; Eggen AE; Risberg T; Wist EA; Flote VG; Furberg AS; Wilsgaard T; Akslen LA; McTiernan A
    Breast Cancer Res Treat; 2016 Jan; 155(2):345-54. PubMed ID: 26740213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinicopathological characteristics and prognosis of different molecular types of breast cancer].
    Liu ZF; Chen C; Yao XL; Sun SR
    Zhonghua Yi Xue Za Zhi; 2016 Jun; 96(22):1733-7. PubMed ID: 27356638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is biological subtype prognostic of locoregional recurrence risk in women with pT1-2N0 breast cancer treated with mastectomy?
    Truong PT; Sadek BT; Lesperance MF; Alexander CS; Shenouda M; Raad RA; Taghian AG
    Int J Radiat Oncol Biol Phys; 2014 Jan; 88(1):57-64. PubMed ID: 24161421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk.
    Furberg AS; Veierød MB; Wilsgaard T; Bernstein L; Thune I
    J Natl Cancer Inst; 2004 Aug; 96(15):1152-60. PubMed ID: 15292387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy.
    Denkert C; von Minckwitz G; Darb-Esfahani S; Lederer B; Heppner BI; Weber KE; Budczies J; Huober J; Klauschen F; Furlanetto J; Schmitt WD; Blohmer JU; Karn T; Pfitzner BM; Kümmel S; Engels K; Schneeweiss A; Hartmann A; Noske A; Fasching PA; Jackisch C; van Mackelenbergh M; Sinn P; Schem C; Hanusch C; Untch M; Loibl S
    Lancet Oncol; 2018 Jan; 19(1):40-50. PubMed ID: 29233559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations between serum lipids and breast cancer incidence and survival in the E3N prospective cohort study.
    His M; Dartois L; Fagherazzi G; Boutten A; Dupré T; Mesrine S; Boutron-Ruault MC; Clavel-Chapelon F; Dossus L
    Cancer Causes Control; 2017 Jan; 28(1):77-88. PubMed ID: 27864712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of age, intrinsic subtype and local treatment on long-term local-regional recurrence and breast cancer mortality among low-risk breast cancer patients.
    Laurberg T; Alsner J; Tramm T; Jensen V; Lyngholm CD; Christiansen PM; Overgaard J
    Acta Oncol; 2017 Jan; 56(1):59-67. PubMed ID: 27846764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.